Jupiter Asset Management Ltd. Invests $2.44 Million in Alignment Healthcare, Inc. $ALHC

Jupiter Asset Management Ltd. acquired a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 174,084 shares of the company’s stock, valued at approximately $2,437,000. Jupiter Asset Management Ltd. owned 0.09% of Alignment Healthcare at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of ALHC. Vanguard Group Inc. boosted its stake in shares of Alignment Healthcare by 13.2% in the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company’s stock worth $206,941,000 after acquiring an additional 1,295,825 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its holdings in shares of Alignment Healthcare by 5.0% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 9,078,113 shares of the company’s stock worth $169,035,000 after acquiring an additional 429,071 shares during the period. Wellington Management Group LLP grew its holdings in shares of Alignment Healthcare by 0.9% in the first quarter. Wellington Management Group LLP now owns 7,509,057 shares of the company’s stock valued at $139,819,000 after purchasing an additional 70,557 shares during the period. 8 Knots Management LLC increased its position in Alignment Healthcare by 28.9% during the first quarter. 8 Knots Management LLC now owns 4,715,472 shares of the company’s stock worth $87,802,000 after purchasing an additional 1,056,777 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in Alignment Healthcare by 9.7% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,199,421 shares of the company’s stock worth $40,954,000 after purchasing an additional 193,644 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on ALHC shares. KeyCorp upgraded shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 target price on the stock in a report on Monday, August 25th. Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 28th. Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, October 8th. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $22.00 price objective on shares of Alignment Healthcare in a report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $19.85.

Insider Transactions at Alignment Healthcare

In related news, CEO John E. Kao sold 355,018 shares of the company’s stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $5,825,845.38. Following the sale, the chief executive officer directly owned 4,533,568 shares of the company’s stock, valued at $74,395,850.88. This represents a 7.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Hyong Kim sold 51,379 shares of the stock in a transaction that occurred on Thursday, October 9th. The stock was sold at an average price of $17.57, for a total transaction of $902,729.03. Following the sale, the insider owned 362,333 shares in the company, valued at approximately $6,366,190.81. This trade represents a 12.42% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 7,593,948 shares of company stock valued at $122,396,905. 7.00% of the stock is owned by corporate insiders.

Alignment Healthcare Price Performance

ALHC opened at $16.77 on Friday. The stock’s 50-day moving average price is $16.97 and its 200 day moving average price is $15.43. Alignment Healthcare, Inc. has a 12-month low of $10.18 and a 12-month high of $21.06. The firm has a market cap of $3.36 billion, a price-to-earnings ratio of -139.75 and a beta of 1.17. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.03. The company had revenue of $993.70 million during the quarter, compared to the consensus estimate of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.Alignment Healthcare’s revenue was up 43.5% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.14) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, sell-side analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.